BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35370941)

  • 1. The Changes of Irisin and Inflammatory Cytokines in the Age-Related Macular Degeneration and Retinal Vein Occlusion.
    Li X; Cao X; Zhao M; Bao Y
    Front Endocrinol (Lausanne); 2022; 13():861757. PubMed ID: 35370941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
    Jung SH; Kim KA; Sohn SW; Yang SJ
    Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential analysis of aqueous humor cytokine levels in patients with macular edema secondary to diabetic retinopathy or retinal vein occlusion.
    Hu KK; Tian CW; Li MH; Wu T; Gong M; Wei XL; Du YR; Hui YN; Du HJ
    Int J Ophthalmol; 2023; 16(7):1041-1046. PubMed ID: 37465512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion.
    Yong H; Qi H; Yan H; Wu Q; Zuo L
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3243-3250. PubMed ID: 34059950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aqueous semaphorin 3A level correlates with retinal macular oedema and ganglion cell degeneration in patients with retinal vein occlusion.
    Guo S; Ren J; Li Z; Fan X; Qin L; Li J
    Acta Ophthalmol; 2019 May; 97(3):273-278. PubMed ID: 30803163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of aqueous concentrations of angiogenic and inflammatory cytokines in diabetic macular oedema and macular oedema due to branch retinal vein occlusion.
    Lee WJ; Kang MH; Seong M; Cho HY
    Br J Ophthalmol; 2012 Nov; 96(11):1426-30. PubMed ID: 22930681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in aqueous concentrations of cytokines in macular edema secondary to branch and central retinal vein occlusion.
    Feng J; Zhao T; Zhang Y; Ma Y; Jiang Y
    PLoS One; 2013; 8(7):e68149. PubMed ID: 23861862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy.
    Shchuko AG; Zlobin IV; Iureva TN; Ostanin AA; Chernykh ER; Mikhalevich IM
    Indian J Ophthalmol; 2015 Dec; 63(12):905-11. PubMed ID: 26862095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
    Sohn HJ; Han DH; Lee DY; Nam DH
    Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Level of vascular endothelial growth factor 165b in human aqueous humor.
    Baba T; Bikbova G; Kitahashi M; Yokouchi H; Oshitari T; Yamamoto S
    Curr Eye Res; 2014 Aug; 39(8):830-6. PubMed ID: 24502617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of soluble vascular endothelial growth factor receptors-1 and -2, their ligands, and other factors in branch retinal vein occlusion with macular edema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Invest Ophthalmol Vis Sci; 2014 Jun; 55(6):3878-85. PubMed ID: 24894397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of soluble vascular endothelial growth factor receptor signaling and other factors or cytokines in central retinal vein occlusion with macular edema.
    Noma H; Mimura T; Yasuda K; Shimura M
    Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1122-8. PubMed ID: 25634982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
    Lim JW
    Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression profiles of cytokines and chemokines in vitreous fluid in diabetic retinopathy and central retinal vein occlusion.
    Suzuki Y; Nakazawa M; Suzuki K; Yamazaki H; Miyagawa Y
    Jpn J Ophthalmol; 2011 May; 55(3):256-263. PubMed ID: 21538000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.
    Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Hirayama T; Tamura H; Yamashita H; Minamoto A; Mishima HK
    Eye (Lond); 2008 Jan; 22(1):42-8. PubMed ID: 16826241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
    Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
    Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of inflammatory cytokines in the aqueous humour for management of macular diseases.
    Yi QY; Wang YY; Chen LS; Li WD; Shen Y; Jin Y; Yang J; Wang Y; Yuan J; Cheng L
    Acta Ophthalmol; 2020 May; 98(3):e309-e315. PubMed ID: 31531945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion.
    Noma H; Funatsu H; Mimura T; Harino S; Hori S
    Eur J Ophthalmol; 2010; 20(2):402-9. PubMed ID: 19967679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features.
    Inagaki S; Shimazawa M; Otsu W; Araki T; Numata Y; Nakamura S; Tsusaki H; Hara H
    Curr Neurovasc Res; 2021; 18(1):123-133. PubMed ID: 32867658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab.
    Funk M; Kriechbaum K; Prager F; Benesch T; Georgopoulos M; Zlabinger GJ; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1025-32. PubMed ID: 19060280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.